Technical Analysis for CSTL - Castle Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Up | Up |
| See historical CSTL trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Fell Below 20 DMA | Bearish | 9.50% | |
| New Downtrend | Bearish | 9.50% | |
| Wide Range Bar | Range Expansion | 9.50% | |
| Outside Day | Range Expansion | 9.50% | |
| Lower Bollinger Band Touch | Weakness | 9.50% | |
| Narrow Range Bar | Range Contraction | 0.51% | |
| NR7 | Range Contraction | 0.51% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.55% | |
| Bearish Engulfing | Bearish | 2.93% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2019
- Sector: Healthcare
- Industry: Diagnostics & Research
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Medicine Health Cancer Clinical Medicine Medical Tests Gene Expression Melanoma Metastasis
Medicine Health Cancer Clinical Medicine Medical Tests Gene Expression Melanoma Metastasis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 31.16 |
| 52 Week Low | 15.26 |
| Average Volume | 111,034 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 23.63 |
| 20-Day Moving Average | 28.25 |
| 10-Day Moving Average | 28.86 |
| Average True Range | 1.93 |
| ADX | 28.78 |
| +DI | 20.75 |
| -DI | 21.88 |
| Chandelier Exit (Long, 3 ATRs ) | 25.36 |
| Chandelier Exit (Short, 3 ATRs ) | 30.13 |
| Upper Bollinger Band | 30.42 |
| Lower Bollinger Band | 26.08 |
| Percent B (%b) | 0.79 |
| BandWidth | 15.35 |
| MACD Line | 1.41 |
| MACD Signal Line | 1.62 |
| MACD Histogram | -0.2123 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 34.48 | ||||
| Resistance 3 (R3) | 34.02 | 31.89 | 33.65 | ||
| Resistance 2 (R2) | 31.89 | 30.63 | 32.13 | 33.37 | |
| Resistance 1 (R1) | 30.70 | 29.84 | 31.30 | 31.16 | 33.10 |
| Pivot Point | 28.57 | 28.57 | 28.87 | 28.81 | 28.57 |
| Support 1 (S1) | 27.38 | 27.31 | 27.98 | 27.84 | 25.90 |
| Support 2 (S2) | 25.25 | 26.52 | 25.49 | 25.63 | |
| Support 3 (S3) | 24.06 | 25.25 | 25.35 | ||
| Support 4 (S4) | 24.52 |
